Literature DB >> 16822688

The O-antigen affects replication of Salmonella enterica serovar Typhimurium in murine macrophage-like J774-A.1 cells through modulation of host cell nitric oxide production.

Eva Bjur1, Sofia Eriksson-Ygberg, Mikael Rhen.   

Abstract

O-antigen-proficient and defined O-antigen-deficient mutants of Salmonella enterica serovar Typhimurium were compared for intracellular replication and induction of nitric oxide (NO) expression in the murine macrophage-like cell line J774-A.1. While O-antigen-proficient bacteria replicated and provoked induction of host cell NO synthesis to expected levels, DeltawaaK, DeltawaaL and DeltawaaKL mutants displayed increased growth yields and induction of significantly lower levels of macrophage NO production. The downregulation of NO production did not involve suppression of inducible nitric oxide synthase (iNOS) expression, yet it depended on bacterial protein synthesis during infection of J774-A.1 cells. In contrast, when inhibitor substances were used to block iNOS activity, the growth yield of the wild type significantly exceeded that of the DeltawaaL mutant bacteria. Inactivation of the Salmonella pathogenicity island 1 (SPI1)-associated bacterial type III secretion system did not affect intracellular replication in the wild type or the DeltawaaL background. However, inactivation of the SPI2-associated type III secretion strongly abrogated bacterial intracellular replication, and the DeltawaaLDeltassaV double mutant lost the ability to suppress NO expression. The results imply that a lack of O-antigen may increase bacterial fitness in J774-A.1 cells through suppression of iNOS activity, and that the O-antigen may protect against NO-independent restriction of bacterial intracellular replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822688     DOI: 10.1016/j.micinf.2006.02.025

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

Review 1.  Bacterial manipulation of innate immunity to promote infection.

Authors:  Lautaro Diacovich; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2010-02       Impact factor: 60.633

2.  Thioredoxin 1 promotes intracellular replication and virulence of Salmonella enterica serovar Typhimurium.

Authors:  Eva Bjur; Sofia Eriksson-Ygberg; Fredrik Aslund; Mikael Rhen
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

3.  Effect of the O-antigen length of lipopolysaccharide on the functions of Type III secretion systems in Salmonella enterica.

Authors:  Stefanie U Hölzer; Markus C Schlumberger; Daniela Jäckel; Michael Hensel
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

4.  Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium.

Authors:  Aurel Negrea; Eva Bjur; Sofia Eriksson Ygberg; Mikael Elofsson; Hans Wolf-Watz; Mikael Rhen
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

5.  Omeprazole antagonizes virulence and inflammation in Salmonella enterica-infected RAW264.7 cells.

Authors:  Speranta Puiac; Aurel Negrea; Agneta Richter-Dahlfors; Laura Plant; Mikael Rhen
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

6.  The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice.

Authors:  Beatriz San Román; Victoria Garrido; Pilar-María Muñoz; Laura Arribillaga; Begoña García; Ximena De Andrés; Virginia Zabaleta; Cristina Mansilla; Inmaculada Farrán; Iñigo Lasa; Damián De Andrés; Beatriz Amorena; Juan-José Lasarte; María-Jesús Grilló
Journal:  Vet Res       Date:  2012-04-19       Impact factor: 3.683

7.  LPS Remodeling Triggers Formation of Outer Membrane Vesicles in Salmonella.

Authors:  Wael Elhenawy; Michael Bording-Jorgensen; Ezequiel Valguarnera; M Florencia Haurat; Eytan Wine; Mario F Feldman
Journal:  MBio       Date:  2016-07-12       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.